✦ LIBER ✦

Very low density lipoprotein receptor in Alzheimer disease

✍ Scribed by Nicole Helbecque; Philippe Amouyel

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 65 KB
Volume: 50
Category: Article
ISSN: 1059-910X
DOI: 10.1002/1097-0029(20000815)50:4<273::aid-jemt4>3.0.co;2-0

No coin nor oath required. For personal study only.

✦ Synopsis

The apolipoprotein (APO) E4 isoform is associated with an accelerated rate of Alzheimer disease (AD) expression in sporadic as well as late-onset familial forms of the disease but the precise mechanism is unknown. In an attempt to approach the possible mechanisms involved, APOE receptors have been studied. They all belong to the low density lipoprotein (LDL) receptor family and share the same structural motifs. Some of them are preferentially expressed in the brain such as the LDL receptor related protein, the apolipoprotein E receptor 2, and the very low density lipoprotein (VLDL) receptor. These receptors have been suspected to be involved in Alzheimer disease at various levels. Among them, the VLDL receptor was extensively explored. Although genetic studies conducted on a polymorphism in the promoter of the VLDL receptor in Japanese and Caucasian populations gave divergent results, this does not exclude a possible involvement of the VLDL receptor in AD.

📜 SIMILAR VOLUMES

Risk of Alzheimer's disease is associate

Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in northern Ireland

✍ McIlroy, Stephen P.; Vahidassr, M. Djamil; Savage, David A.; Patterson, Christop 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB 👁 2 views

The -4 allele of apolipoprotein E (APOE) is associated with increased risk of Alzheimer's disease (AD), but the pathogenic mechanism is unknown. The 5-repeat allele of a CGG repeat polymorphism in the 5 untranslated region of the very low-density lipoprotein receptor (VLDL-R) gene, a receptor for ap

No association between the very low dens

No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples

✍ Danielle Fallin; Ann C. Gauntlett; Paul Scibelli; Xingang Cai; Ranjan Duara; Mic 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

It is now commonly known that possession of one of the three common alleles of the apolipoprotein E (APOE) gene (allele epsilon 4) confers an increased risk for both familial and sporadic Alzheimer's disease (AD), and that this risk is dose-dependent. Other genes that may play a role in AD, either t

Lack of association of very low density

Lack of association of very low density lipoprotein receptor gene polymorphism with caucasian Alzheimer's disease

✍ Kaoru Okuizumi; Osamu Onodera; Hajime Tanaka; Dr Shoji Tsuji; Koji Seki; Yoshio 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

atrophy (SMA) type I1 and 111 in the same sibship are not caused by different alleles at the SMA locus on 5q. Am J Hum

No association between low density lipop

No association between low density lipoprotein receptor genetic variants and Alzheimer's disease risk

✍ Eloy Rodríguez; Ignacio Mateo; Javier Llorca; Coro Sánchez-Quintana; Jon Infante 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## Abstract A number of studies suggest that brain cholesterol metabolism may play a role in Alzheimer's disease (AD) development, probably through modulation of amyloid beta production. The discovery that apolipoprotein E (__APOE__) ε4 allele is a risk factor for sporadic AD raises the possibility

Serum pseudocholinesterase and very-low-

Serum pseudocholinesterase and very-low-density lipoprotein metabolism

✍ Dr. K. M. Kutty; R. H. Payne 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

Serum pseudocholinesterase (PChE) was discovered in 1932. Since this protein mimics many of the catalytic properties of acetylcholinesterase, it has traditionally been referred to as PChE, even though its true biological function is unknown. Serum PChE is synthesized in the liver and secreted into t

Lack of association of trinucleotide rep

Lack of association of trinucleotide repeat polymorphisms in the very-low-density lipoprotein receptor gene with Alzhelner's disease

✍ Haeyong Chung Ba; Carol T. Roberts; Steven Greenberg; G. William Rebeck; Richard 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

Inheritance of the apolipoprotein E E 4 allele is a risk factor for Alzheimer's disease (AD). A recent report studying Japanese patients suggested that a polymorphism of a trinucleotide repeat in the 5' untranslated region of an apolipoprotein E receptor, the very-low-density lipoprotein receptor, i